Executive record

Isabel Kalofonos

Chief Commercial Officer at Crinetics Pharmaceuticals, Inc.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:isabel-kalofonos-crnxVersion: public-0As of: 2026-09-29

Not yet claimed9 published Claims3 sources
  • Executive

Key Claims

Biography

Served as Chief Commercial Officer at Fulcrum Therapeutics; previously SVP and Chief Commercial Officer at ImmunoGen leading successful launch of ELAHERE; held roles at Galderma and Takeda Pharmaceuticals with increasing responsibility in commercial leadership and franchise management.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Executive career

  1. Current · dates not publishedChief Commercial Officer · Crinetics Pharmaceuticals, Inc.
  2. 2026 to end not publishedExecutive title: Chief Commercial Officer · Organization not publishedCRNX DEF 14A executive officers

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. CRNX DEF 14A executive officers

    sec filing · Source published: Apr 29, 2026 · Retrieved: May 16, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Executive company: Executive at Crinetics Pharmaceuticals, Inc. · Claim reviewed: May 16, 2026
    • Executive title: Executive title: Chief Commercial Officer · Claim reviewed: May 16, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 16, 2026

  2. Open source

    sec def 14a · Source published: Apr 29, 2026 · Retrieved: Sep 6, 2026

    Supports 1 claim
    • Professional Role: Chief Commercial Officer at Crinetics Pharmaceuticals, Inc. · Claim reviewed: Sep 6, 2026

  3. CRNX executive roster source

    sec filing · Source published: Date unavailable · Retrieved: May 3, 2026

    Supports 5 claims
    • AI expertise: AI expertise: not identified in the cited filing · Claim reviewed: May 3, 2026
    • AI governance relevance: AI governance relevance: not identified in the cited filing · Claim reviewed: May 3, 2026
    • Executive company: Executive at Crinetics Pharmaceuticals, Inc. · Claim reviewed: May 16, 2026
    • Executive function: Other Executive (OTHER_EXECUTIVE) · Claim reviewed: May 3, 2026
    • Executive title: Executive title: Chief Commercial Officer · Claim reviewed: May 16, 2026